Antonios Apostolopoulos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Antonios Apostolopoulos has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Shintaro Iwasaki
RIKEN
2 shared publications - Yuichi Shichino
University of Tsukuba: Tsukuba Daigaku
2 shared publications Hitomi Tsuiji
Education and Research Division of Pharmacy, School of Pharmacy, Aichi Gakuin University, Nagoya, Japan
1 shared publication- Hitomi Tsuiji
Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan
1 shared publication - Naohiro Kawamoto
RNA Systems Biochemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Japan
1 shared publication Siu Yu A. Chow
Institute of Industrial Science, The University of Tokyo, Meguro-ku, Japan
1 shared publication
Latest Publications
- Open Access
- 11 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
dCas13-mediated translational repression for accurate gene silencing in mammalian cells
Current gene silencing tools based on RNA interference (RNAi) or, more recently, clustered regularly interspaced short palindromic repeats (CRISPR)‒Cas13 systems have critical drawbacks, such as off-target effects (RNAi) or collateral mRNA cleavage (CRISPR‒Cas13). Thus, a more specific method of gene knockdown is needed. Here, we develop CRISPRδ, an approach for translational silencing, harnessing catalytically inactive Cas13 proteins (dCas13). Owing to its tight association with mRNA, dCas13 serves as a physical roadblock for scanning ribosomes during translation initiation and does not affect mRNA stability. Guide RNAs covering the start codon lead to the highest efficacy regardless of the translation initiation mechanism: cap-dependent, internal ribosome entry site (IRES)-dependent, or repeat-associated non-AUG (RAN) translation. Strikingly, genome-wide ribosome profiling reveals the ultrahigh gene silencing specificity of CRISPRδ. Moreover, the fusion of a translational repressor to dCas13 further improves the performance. Our method provides a framework for translational repression-based gene silencing in eukaryotes.
- 11 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
Open AccessdCas13-mediated translational repression for accurate gene silencing in mammalian cells
Current gene silencing tools based on RNA interference (RNAi) or, more recently, clustered regularly interspaced short palindromic repeats (CRISPR)‒Cas13 systems have critical drawbacks, such as off-target effects (RNAi) or collateral mRNA cleavage (CRISPR‒Cas13). Thus, a more specific method of gene knockdown is needed. Here, we develop CRISPRδ, an approach for translational silencing, harnessing catalytically inactive Cas13 proteins (dCas13). Owing to its tight association with mRNA, dCas13 serves as a physical roadblock for scanning ribosomes during translation initiation and does not affect mRNA stability. Guide RNAs covering the start codon lead to the highest efficacy regardless of the translation initiation mechanism: cap-dependent, internal ribosome entry site (IRES)-dependent, or repeat-associated non-AUG (RAN) translation. Strikingly, genome-wide ribosome profiling reveals the ultrahigh gene silencing specificity of CRISPRδ. Moreover, the fusion of a translational repressor to dCas13 further improves the performance. Our method provides a framework for translational repression-based gene silencing in eukaryotes.
- Open Access
CRISPRδ: dCas13-mediated translational repression for accurate gene silencing in mammalian cells
Summary: Current gene silencing tools based on RNA interference (RNAi) or, more recently, clustered regularly interspaced short palindromic repeats (CRISPR)⃩Cas13 systems, have critical drawbacks, such as off-target effects (RNAi) or collateral mRNA cleavage (CRISPR⃩Cas13). Thus, a more specific method of gene knockdown is needed. Here, we developed “CRISPRδ”, an approach for translational silencing, harnessing catalytically inactive Cas13 proteins (dCas13). Owing to its tight association with mRNA, dCas13 serves as a physical roadblock for scanning ribosomes during translation initiation and does not affect mRNA stability. Guide RNAs covering the start codon lead to the highest efficacy regardless of the translation initiation mechanism: cap-dependent or internal ribosome entry site (IRES)-dependent translation. Strikingly, genome-wide ribosome profiling revealed the extremely high gene knockdown specificity of CRISPRδ. Moreover, fusion of a translational repressor to dCas13 ensured further improvement of the knockdown efficacy. Our method provides a framework for translational repression-based gene silencing in eukaryotes.
Open AccessCRISPRδ: dCas13-mediated translational repression for accurate gene silencing in mammalian cells
Summary: Current gene silencing tools based on RNA interference (RNAi) or, more recently, clustered regularly interspaced short palindromic repeats (CRISPR)⃩Cas13 systems, have critical drawbacks, such as off-target effects (RNAi) or collateral mRNA cleavage (CRISPR⃩Cas13). Thus, a more specific method of gene knockdown is needed. Here, we developed “CRISPRδ”, an approach for translational silencing, harnessing catalytically inactive Cas13 proteins (dCas13). Owing to its tight association with mRNA, dCas13 serves as a physical roadblock for scanning ribosomes during translation initiation and does not affect mRNA stability. Guide RNAs covering the start codon lead to the highest efficacy regardless of the translation initiation mechanism: cap-dependent or internal ribosome entry site (IRES)-dependent translation. Strikingly, genome-wide ribosome profiling revealed the extremely high gene knockdown specificity of CRISPRδ. Moreover, fusion of a translational repressor to dCas13 ensured further improvement of the knockdown efficacy. Our method provides a framework for translational repression-based gene silencing in eukaryotes.